abrdn private equity trust share price struggles

NAV performance holds up

Kathleen Gallagher
clock • 2 min read

The £1.1bn abrdn private equity opportunities trust experienced net asset value growth in the year to end of September 2022, however, public sentiment hindered its share price performance, leading it underperforming its benchmark.

In the annual report published Tuesday (31 January), the trust said for the 12 months to the end of September 2022, APEO experienced a NAV total return of 14.1%, with the valuation of the underlying portfolio increasing 10.5%. However, "deterioration in public market sentiment" led the share price to fall 15.1% during the period, underperforming the FTSE All-Share index, which was down 4%. Smaller board and new manager for reformed JPM Russia portfolio As a result of the contrast between the two, the NAV on the trust widened to 45.6% at the end of September, and ranged between 11.2...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Investment Trusts

Edinburgh Worldwide pledges £130m capital return amid changes to boost performance

Edinburgh Worldwide pledges £130m capital return amid changes to boost performance

Capital return opportunity in 2025

Valeria Martinez
clock 20 November 2024 • 3 min read
Miton UK MicroCap trust headed for voluntary wind-up

Miton UK MicroCap trust headed for voluntary wind-up

‘Challenging’ performance and dwindling assets

Cristian Angeloni
clock 19 November 2024 • 1 min read
Worldwide Healthcare backs board members after shareholders express independence concerns

Worldwide Healthcare backs board members after shareholders express independence concerns

Doug McCutcheon and Sven Borho

Linus Uhlig
clock 18 November 2024 • 2 min read
Trustpilot